The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

February 28, 2007

Conditions
Hypertension
All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00728858 - The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients | Biotech Hunter | Biotech Hunter